Skip to main
SEPN

Septerna Inc (SEPN) Stock Forecast & Price Target

Septerna Inc (SEPN) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Septerna Inc., with an enterprise value of approximately $430 million, presents a compelling investment opportunity due to its innovative approach in GPCR oral small molecule drug discovery through its Native Complex Platform. The company's diverse pipeline, featuring candidates like SEP-786, SEP-631, and others, targets significant therapeutic areas, and early promising results from preclinical studies suggest a potential for enhanced efficacy akin to established treatments such as Xolair. The management's confidence in efficiently progressing with Phase 1 trials and the prospect of fruitful partnerships underscores the potential for substantial upside in the company's valuation over the long term.

Bears say

The analysis indicates that Septerna Inc faces several significant risks that could negatively impact its stock outlook. Key concerns include potential delays in clinical development and setbacks in trials for its leading candidates like SEP-631, as well as critical partnership risks with Novo Nordisk that may jeopardize strategic collaborations. Additionally, the company's ability to secure regulatory approvals for its product candidates and achieve expected market penetration rates remains uncertain, compounded by the potential for long-term dilution, further straining investor confidence.

Septerna Inc (SEPN) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Septerna Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Septerna Inc (SEPN) Forecast

Analysts have given Septerna Inc (SEPN) a Strong Buy based on their latest research and market trends.

According to 6 analysts, Septerna Inc (SEPN) has a Strong Buy consensus rating as of Feb 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $33.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $33.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Septerna Inc (SEPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.